RIBASPHERE RibaPak (Kadmon Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the RIBASPHERE RibaPak drug offered from Kadmon Pharmaceuticals, LLC. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Kadmon Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | ribavirin |
| SUBSTANCE NAME: | RIBAVIRIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2010-01-01 |
| END MARKETING DATE: | 0000-00-00 |
RIBASPHERE RibaPak HUMAN PRESCRIPTION DRUG Details:
| Item Description | RIBASPHERE RibaPak from Kadmon Pharmaceuticals, LLC |
| LABELER NAME: | Kadmon Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 400(mg/1) |
| START MARKETING DATE: | 2010-01-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66435-105_dffc1bdc-d81c-457e-ace7-ee5c6032f7b0 |
| PRODUCT NDC: | 66435-105 |
| APPLICATION NUMBER: | ANDA077456 |
Other RIBAVIRIN Pharmaceutical Manufacturers / Labelers:
